MedCanHub: a platform developed by Cellen aimed at reducing barriers of access to unlicensed cannabis-based medicinal products during the COVID-19 pandemic.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical medicine"
DOI: 10.7861/clinmed.21-2-s29
Abstract: Unlicensed cannabis-based medicinal products (UCBPMs) were reclassified from Schedule 1 to Schedule 2 in 2018 in the UK, allowing doctors on the Specialist Register of the General Medical Council to legally issue prescriptions for UCBPMs.[1,2][1]… read more here.
Keywords: platform developed; based medicinal; medicinal products; cannabis based ... See more keywords